Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Siret Kivistik has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Educational Needs Regarding Mental Health of Professionals Working with Young Adults with Cancer: A European Survey

    by Sid Morsink, Leonieke W. Kranenburg, Johanna Berg, Evangeli Bista, Saintuya Dashondog, Siret Kivistik, Mari Lahti, Carmen Monge-Montero, Joaquim Oliveira Lopes, Evanthia Sakellari, et al.

    Worldwide, an increase in cancer diagnosis has been identified, especially in people under 50 years and in young adults (YAs, age group 18–39 years)

  • Open Access

    Radiation therapist research engagement and culture: findings from the ESTRO Radiation TherapisT workshop

    by Yat Man Tsang, Siret Kivistik, Lynsey Devlin, Valbona Bali, Erica Bennett, Jenna Dean, Hannah Dyer, Cynthia Eccles, Laurent Marmy, Melissa Martel, et al.

    Background and Purpose: Despite widespread recognition of the value of research among radiation therapists (RTTs), sustained engagement remains low across international settings. This study aimed to explore RTT perspectives on research engagement, characterise the cultural conditions shaping participation, and generate structured recommendations for strengthening RTT research culture.Materials and Methods: A qualitative, workshop-based study was conducted through the ESTRO RTT workshop series. A sixteen-member Research Engagement Expert Reference Group (RE-ERG), drawn from ten countries, participated in two virtual sessions. The cultural web framework was applied in Workshop 1 to map research culture across six organisational elements. In Workshop 2, participants validated findings and developed recommendations structured around three strategic pillars: Preserve, Adapt, and Innovate (PAI). Real-time polling and recorded transcripts were analysed using deductive thematic analysis informed by the cultural web framework.Results: Two cross-cutting tensions emerged: a persistent recognition-to-practice gap in which strong endorsement of research coexisted with structural barriers to participation, and a reliance on individual commitment rather than systemic support, with research frequently described as “hidden work” conducted outside rostered hours. 15/16 participants (94%) agreed that RTTs could make a significant contribution to research. The Preserve pillar identified five foundational strengths including collaboration, mentorship, visibility, organisational support, and patient-focused research. The Adapt pillar generated recommendations addressing education, governance simplification, career pathway clarity, and protected time. The Innovate pillar emphasised research champion roles, graduated fellowship schemes, digital collaboration platforms, and embedding research within departmental objectives and international networks.Conclusion: RTTs collectively articulate a clear and actionable vision for research culture development, yet realising it requires coordinated action from departments, national professional bodies, and international organisations. Applying the cultural web framework alongside the PAI pillars produced practitioner-grounded recommendations that move beyond barrier identification towards infrastructures that make research participation an expected and enabled dimension of RTT professional practice.

  • The Factors for Success and Lack of Success in the Breast Cancer Patient Care Pathway: A Qualitative Study From the Health Care Staff Perspective

    by Eija Metsälä, Tanja Schroderus-Salo, Kjersti Straume, Bergliot Strom, Laurent Marmy, Mona Øynes, José A. Pires Jorge, Liis Randle, Siret Kivistik

    To produce information about factors related to successful and unsuccessful breast cancer care pathways from the health care staff perspective. An electronic qualitative survey was used to collect data simultaneously from hospitals located in four different countries, focusing on four professional groups: diagnostic radiographers; radiation therapists; breast cancer nurses; and biomedical laboratory scientists (n = 23). The hospitals participating in the study treat breast cancer patients and research permits were applied from all of them. Data was analysed by deductive thematic analysis. At the core of a successful breast cancer care pathway is the right content and timely information provided to the patient at the pace the patient is able to adopt. This is especially highlighted at the beginning of the treatment process. In regards to diagnostic services, rigorous execution of mammography, sampling techniques and analyses were seen as important. Staff also valued the importance of aftercare and follow-up, and highlighted the fact that the patient should be given a chance to keep in close contact with care and treatment staff, even after their active treatment process has finished. Health care staff recognized the same success factors for optimal breast cancer care and treatment pathways as patients reported in previous studies, yet more emphasis was put on patient characteristics and the technical performance features of the process. Both patient and staff viewpoints should be taken into account in planning breast cancer care pathways.


  • Open Access

    Breast cancer patients’ experiences on their individual care pathway: A qualitative study

    by E. Metsälä, S. Kivistik, K. Straume, L. Marmy, J.A.P. Jorge, B. Strom


  • Complementary medicine use among cancer patients receiving radiotherapy and chemotherapy: methods, sources of information and the need for counselling

    by R. Pihlak, R. Liivand, O. Trelin, H. Neissar, I. Peterson, S. Kivistik, K. Lilo, J. Jaal

    Complementary medicine (CM) use is common among cancer patients. However, little is known about CM products that are utilised during radiotherapy and/or chemotherapy. Out of 62 cancer patients who completed a specialised survey, 35 (56%) consumed some type of CM during active anti-cancer therapy. Cancer patients reported the use of herbal teas (52%), vitamins and other dietary supplements (45%), vegetables and juices (39%), special diets (19%), herbal medicines, including Chinese medicines (19%) and 'immunomodulators' (3%). Most of patients (86%) consumed CM products every day. However, nearly 47% of CM users did not admit this to their oncologists. Majority of CM users (85%) were convinced that supplementary products increase the efficacy of standard anti-cancer therapy and prolong their survival. Information about CM was mainly obtained through internet sources (36%), books and brochures (25%). Although most CM users (82%) trusted the received information, 73% of them admitted that additional information about CM methods would be necessary. Patients would like to receive additional information through a specialised consultation (60%), but also from brochures (44%) and the internet (20%). Adequate counselling of patients is of paramount importance since some CM methods may cause significant side effects and decrease the efficacy of radiotherapy and/or chemotherapy.